Skip to content
10-Q

Quarterly Report

ANGIOGENEX, INC.

0001469709-18-000091

← back to feed
Filed
May 14, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 14, 2018 29.39M sh
Cash And Equivalents Q1 2018 · Mar 31, 2018 $380.88K
Cash And Equivalents Q1 2018 · Dec 31, 2017 $493.68K
Cash And Equivalents Q1 2018 · Mar 31, 2017 $216.73K
Cash And Equivalents Q1 2018 · Dec 31, 2016 $272.47K
Stockholders Equity Q1 2018 · Mar 31, 2018 −$845.99K
Current Liabilities Q1 2018 · Mar 31, 2018 $1.21M
Current Liabilities Q1 2018 · Dec 31, 2017 $1.14M
Current Assets Q1 2018 · Mar 31, 2018 $393.75K
Current Assets Q1 2018 · Dec 31, 2017 $515.31K
Total Assets Q1 2018 · Mar 31, 2018 $393.75K
Total Assets Q1 2018 · Dec 31, 2017 $515.31K
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$55.74K
Sga Expense Q1 2018 · Mar 31, 2017 $56.98K
Rd Expense Q1 2018 · Mar 31, 2017 $30.04K
Net Income Q1 2018 · Mar 31, 2017 −$89.79K
Operating Income Q1 2018 · Mar 31, 2017 −$87.02K